{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:47:40Z","timestamp":1792169260940,"version":"4.4.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"\n Introduction:<\/jats:title>\n Hip arthroscopy has increased in utilization with the improvement of surgical technique and technology. Although the rate of complications has historically been low, patient-specific factors may increase complication risk. The effects of preoperative corticosteroid use and resultant immunosuppression on outcomes following hip arthroscopy are not well understood. This study aimed to compare the rates and odds of 90-day medical complications, emergency department (ED) utilizations, and readmissions between corticosteroid users and nonusers undergoing hip arthroscopy.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n Using the PearlDiver nationwide claims database (2010 to 2021), corticosteroid users (N = 1,735) were propensity score matched in a 1:5 ratio to controls (N = 8,643) based on age, sex, and comorbidities, and Elixhauser comorbidity index. Ninety-day medical complications, ED utilization, and readmissions were compared. Logistic regression models were used to compute odds ratios (ORs) of medical complications, and 90-day ED visits and readmissions in corticosteroid users. Following Bonferroni correction, statistical significance was set at\n P<\/jats:italic>\n < 0.01.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Corticosteroid users demonstrated markedly higher odds of medical complications (OR, 4.75;\n P<\/jats:italic>\n < 0.0001) compared with controls. Corticosteroid users had elevated rates and odds of deep vein thrombosis (1.27% vs. 0.25%; OR, 5.04;\n P<\/jats:italic>\n < 0.0001), pneumonia (5.01% vs. 0.69%; OR, 7.81;\n P<\/jats:italic>\n < 0.0001), blood transfusion (0.98% vs. 0.20%; OR, 5.06;\n P<\/jats:italic>\n < 0.0001), surgical site infections (0.81% vs. 0.23%; OR, 3.51;\n P<\/jats:italic>\n = 0.0003), and deep wound infections (0.69% vs. 0.22%; OR, 3.17;\n P<\/jats:italic>\n = 0.001). Corticosteroid users had higher incidence and odds of ED visits (4.27% vs. 2.04%; OR, 2.15;\n P<\/jats:italic>\n < 0.0001) and readmissions (4.84% vs. 2.07%; OR, 2.43;\n P<\/jats:italic>\n < 0.0001) within 90 days.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Corticosteroid users undergoing hip arthroscopy are at higher risk of 90-day medical complications, ED visits, and readmissions compared with noncorticosteroid users. These findings emphasize the need for careful perioperative planning and risk mitigation strategies for this high-risk group.<\/jats:p>\n <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-01147","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:11:42Z","timestamp":1781878302000},"page":"e3144-e3149","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of 90-Day Medical Complications, Emergency Department Utilizations, and Readmissions for Corticosteroid Users Undergoing Hip Arthroscopy"],"prefix":"10.5435","volume":"34","author":[{"given":"Adam M.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9689-7364","authenticated-orcid":false,"given":"Patrick P.","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Gilat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"R1-20261016","doi-asserted-by":"crossref","first-page":"23259671241277793","DOI":"10.1177\/23259671241277793","article-title":"A multicenter analysis of 3 decades of hip arthroscopy: Evolving techniques and growing patient volumes from 1988 to 2022","volume":"12","author":"Conyer","year":"2024","journal-title":"Orthop J Sports Med"},{"key":"R2-20261016","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/1941738117712675","article-title":"Indications for hip arthroscopy","volume":"9","author":"Ross","year":"2017","journal-title":"Sports Health"},{"key":"R3-20261016","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/0363546515587719","article-title":"Arthroscopic versus open treatment of femoroacetabular impingement: A systematic review of Medium- to long-term outcomes","volume":"44","author":"Nwachukwu","year":"2016","journal-title":"Am J Sports Med"},{"key":"R4-20261016","doi-asserted-by":"crossref","first-page":"402","DOI":"10.32098\/mltj.03.2016.18","article-title":"Complications in hip arthroscopy","volume":"6","author":"Nakano","year":"2016","journal-title":"Muscles, Ligaments Tendons J"},{"key":"R5-20261016","doi-asserted-by":"crossref","first-page":"739","DOI":"10.5435\/JAAOS-D-24-00262","article-title":"Assessing the risk factors for surgical site and deep wound infections following hip arthroscopy: A nationwide study of 75,577 patients","volume":"33","author":"Nian","year":"2025","journal-title":"J Am Acad Orthop Surg"},{"key":"R6-20261016","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijsu.2017.08.557","article-title":"Hip arthroscopy: Indications, outcomes and complications","volume":"54","author":"Jamil","year":"2018","journal-title":"Int J Surg"},{"key":"R7-20261016","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.arthro.2012.11.003","article-title":"Complications and reoperations during and after hip arthroscopy: A systematic review of 92 studies and more than 6,000 patients","volume":"29","author":"Harris","year":"2013","journal-title":"Arthroscopy"},{"key":"R8-20261016","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/ph16091328","article-title":"Effects of preoperative chronic steroid use on postoperative outcomes in orthopedic surgery: A systematic review and meta-analysis","volume":"16","author":"Hung","year":"2023","journal-title":"Pharmaceuticals"},{"key":"R9-20261016","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jhps\/hnx004","article-title":"Hip arthroscopy in the United States: An update following coding changes in 2011","volume":"4","author":"Truntzer","year":"2017","journal-title":"J Hip Preserv Surg"},{"key":"R10-20261016","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.surg.2018.12.016","article-title":"Chronic steroid use as an independent risk factor for perioperative complications","volume":"165","author":"Chouairi","year":"2019","journal-title":"Surgery"},{"key":"R11-20261016","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.amjsurg.2023.01.021","article-title":"Association between chronic steroids and outcomes in hepatobiliary and pancreatic surgery","volume":"226","author":"Jehan","year":"2023","journal-title":"Am J Surg"},{"key":"R12-20261016","doi-asserted-by":"crossref","first-page":"M11","DOI":"10.1530\/EJE-15-0198","article-title":"Adverse effects of glucocorticoids: Coagulopathy","volume":"173","author":"Coelho","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"R13-20261016","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjh.17388","article-title":"Glucocorticoid use and risk of first and recurrent venous thromboembolism: Self-controlled case-series and cohort study","volume":"193","author":"Orsi","year":"2021","journal-title":"Br J Haematol"},{"key":"R14-20261016","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejim.2015.06.005","article-title":"Venous thromboembolism and preoperative steroid use: Analysis of the NSQIP database to evaluate risk in surgical patients","volume":"26","author":"Kantar","year":"2015","journal-title":"Eur J Intern Med"},{"key":"R15-20261016","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/M18-2217","article-title":"Risk of biologics and glucocorticoids in patients with rheumatoid arthritis undergoing arthroplasty: A cohort study","volume":"170","author":"George","year":"2019","journal-title":"Ann Intern Med"},{"issue":"suppl 3","key":"R16-20261016","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s000110050310","article-title":"Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation","volume":"47","author":"Goulding","year":"1998","journal-title":"Inflamm Res"},{"key":"R17-20261016","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1038\/s41467-020-17565-y","article-title":"Preferential inhibition of adaptive immune system dynamics by glucocorticoids in patients after acute surgical trauma","volume":"11","author":"Ganio","year":"2020","journal-title":"Nat Commun"},{"key":"R18-20261016","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00167-019-05415-4","article-title":"Risk factors for 30-day readmission following hip arthroscopy","volume":"28","author":"Hartwell","year":"2020","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"R19-20261016","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.arthro.2019.06.021","article-title":"Unplanned admissions following hip arthroscopy: Incidence and risk factors","volume":"35","author":"Du","year":"2019","journal-title":"Arthroscopy"},{"key":"R20-20261016","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.arth.2016.02.029","article-title":"Cost analysis of total joint arthroplasty readmissions in a bundled payment care improvement initiative","volume":"31","author":"Clair","year":"2016","journal-title":"J Arthroplasty"},{"key":"R21-20261016","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/0363546517749212","article-title":"Risk factors for infection after shoulder arthroscopy in a large medicare population","volume":"46","author":"Cancienne","year":"2018","journal-title":"Am J Sports Med"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:00:36Z","timestamp":1792166436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":21,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-01147","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"2025-09-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}